ENVB (Enveric Biosciences, Inc. Common Stock) Stock Analysis - Insider Trades
Enveric Biosciences, Inc. Common Stock (ENVB) is a publicly traded Healthcare sector company. As of May 21, 2026, ENVB trades at $2.19 with a market cap of $4.27M and a P/E ratio of -0.16. ENVB moved +6.16% today. Year to date, ENVB is -45.41%; over the trailing twelve months it is -86.42%. Its 52-week range spans $1.71 to $99.90. Rallies surfaces ENVB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading ENVB stock inside the company?
Recent ENVB insider activity includes PASQUALONE FRANK bought 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
ENVB Key Metrics
Key financial metrics for ENVB
Metric
Value
Price
$2.19
Market Cap
$4.27M
P/E Ratio
-0.16
EPS
$-13.36
Dividend Yield
0.00%
52-Week High
$99.90
52-Week Low
$1.71
Volume
773
Avg Volume
0
Revenue (TTM)
$-411
Net Income
$-8.22M
Gross Margin
0.00%
Recent ENVB Insider Trades
PASQUALONE FRANK bought 1.00K (~$2.14K) on Sep 15, 2023.
ENVB analyst coverage data. Average price target: $0.00.
Common questions about ENVB
Who is trading ENVB stock inside the company?
Recent ENVB insider activity includes PASQUALONE FRANK bought 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ENVB?
Yes. Rallies tracks ENVB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ENVB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ENVB. It does not provide personalized investment advice.